Bank of New York Mellon’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-151,136
Closed -$747K 4269
2025
Q1
$747K Sell
151,136
-3,249
-2% -$10.3K ﹤0.01% 3224
2024
Q4
$454K Sell
154,385
-4,407
-3% -$18.1K ﹤0.01% 3576
2024
Q3
$749K Sell
158,792
-38,167
-19% -$172K ﹤0.01% 3293
2024
Q2
$758K Buy
196,959
+10,077
+5% +$45.4K ﹤0.01% 3339
2024
Q1
$1,000K Sell
186,882
-10,748
-5% -$50.6K ﹤0.01% 3155
2023
Q4
$844K Buy
197,630
+16,303
+9% +$50.1K ﹤0.01% 3284
2023
Q3
$711K Sell
181,327
-2,893
-2% -$19K ﹤0.01% 3366
2023
Q2
$1.86M Buy
184,220
+43,917
+31% +$465K ﹤0.01% 2880
2023
Q1
$1.43M Buy
140,303
+5,877
+4% +$67.2K ﹤0.01% 2977
2022
Q4
$1.26M Sell
134,426
-2,612
-2% -$36.8K ﹤0.01% 3083
2022
Q3
$1.99M Buy
137,038
+9,457
+7% +$140K ﹤0.01% 2860
2022
Q2
$1.68M Buy
127,581
+40,084
+46% +$546K ﹤0.01% 2934
2022
Q1
$1.49M Sell
87,497
-2,291
-3% -$38.9K ﹤0.01% 3090
2021
Q4
$2.3M Buy
+89,788
New +$2.8M ﹤0.01% 2904

Other funds holding TSVT

Bank of New York Mellon's TSVT Position: Q2 2025 in Review

Bank of New York Mellon sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 151,136 shares — an estimated $747K sold.

Bank of New York Mellon first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $2.3M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Bank of New York Mellon reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 151,136 2seventy bio shares in Q2 2025, an estimated $747K.
  • Bank of New York Mellon first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Bank of New York Mellon's 2seventy bio position peaked at $2.3M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.